- Home
- SENEA vs KRRO Comparison
SENEA vs KRRO Comparison
Compare SENEA & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SENEA | KRRO |
|---|---|---|
| Founded | 1949 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 58.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SENEA | KRRO |
|---|---|---|
| Price | $113.32 | $7.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 76.3K | ★ 424.0K |
| Earning Date | 02-05-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.79 | N/A |
| EPS | ★ 8.61 | N/A |
| Revenue | ★ $1,606,175,000.00 | $7,371,000.00 |
| Revenue This Year | N/A | $144.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.09 | ★ N/A |
| Revenue Growth | ★ 8.33 | N/A |
| 52 Week Low | $70.58 | $5.20 |
| 52 Week High | $129.03 | $55.89 |
Technical Indicators
Market Signals| Indicator | SENEA | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 32.89 |
| Support Level | $110.34 | $7.63 |
| Resistance Level | $113.59 | $8.57 |
| Average True Range (ATR) | 3.18 | 0.69 |
| MACD | -0.45 | 1.25 |
| Stochastic Oscillator | 23.20 | 74.08 |
Price Performance
Historical ComparisonAbout SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.